Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 20/20 | 0.59 |
| ▸ | WDR77 | Q9BQA1 | 19/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18009953 | 1.00 | PRMT5 (0.59) | PRMT5WDR77 | |
| SCHEMBL20475765 | 0.94 | PRMT5 (0.60) | PRMT5WDR77 | |
| SCHEMBL20475853 | 0.94 | PRMT5 (0.59) | PRMT5WDR77 | |
| SCHEMBL20475851 | 0.94 | PRMT5 (0.59) | PRMT5WDR77 | |
| SCHEMBL20475768 | 0.94 | PRMT5 (0.60) | PRMT5WDR77 | |
| SCHEMBL18205053 | 0.92 | PRMT5 (0.58) | PRMT5WDR77 | |
| SCHEMBL18205106 | 0.92 | PRMT5 (0.58) | PRMT5WDR77 | |
| SCHEMBL18009692 | 0.90 | PRMT5 (0.73) | PRMT5WDR77 | |
| SCHEMBL18009848 | 0.90 | PRMT5 (0.73) | PRMT5WDR77 | |
| SCHEMBL18009827 | 0.90 | PRMT5 (0.73) | PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220218732-A1 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) | PRELUDE THERAPEUTICS INCORPORATED | 2022-07-14 | — | — | US | disclosed |
| US-11220524-B2 | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) | PRELUDE THERAPEUTICS INCORPORATED (US) | 2022-01-11 | — | — | US | disclosed |
| US-20210130388-A1 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | PRELUDE THERAPEUTICS, INCORPORATED | 2021-05-06 | — | — | US | disclosed |
| US-9840532-B2 | 5′-substituted nucleoside compounds | ELI LILLY AND COMPANY (US) | 2017-12-12 | — | — | US | disclosed |
| US-20160326208-A1 | 5'-SUBSTITUTED NUCLEOSIDE COMPOUNDS | ELI LILLY AND COMPANY | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130388-A1 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | PRMT5, PRMT6, PRMT1 | PRMT5 1/4885WDR77 59/4885 |
| US-20220218732-A1 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) | PRMT5, PRMT6, PRMT1 | PRMT5 1/4885WDR77 52/4885 |
| US-20160326208-A1 | 5'-SUBSTITUTED NUCLEOSIDE COMPOUNDS | NT5C3B, MCL1, NSUN2 | PRMT5 74/4885WDR77 746/4885 |
| US-11220524-B2 | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) | PRMT5, PRMT6, PRMT1 | PRMT5 1/4885WDR77 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.